Sort
59,101 grants matching “hypertension”
Role of Health Care in Addressing Unhealthy Alcohol Use and Disparities among Aging Women
$629,374Cynthia I Campbell · Kaiser Foundation Research Institute · R01 · FY2025 · AA
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
$629,333Gail Kurr Adler · Brigham And Women'S Hospital · R01 · FY2010 · HL
Role of Skeletal Muscle Health on Poor LIfestyle Related Type 2 Diabetes and Cardiovascular Disease Risk
$629,296Xiaoling Wang · Augusta University · R01 · FY2022 · DK
Improving Hypertension Medication Adherence for Older Adults
$629,288Jeannie Kim Lee · University Of Arizona · R01 · FY2024 · NR
Healing Hearts, Mending Minds in Older Persons with HIV
$629,273Drenna Waldrop-Valverde · Emory University · R01 · FY2016 · NR
Colorado Center for Childhood Liver Disease Research and Education
$629,271Ronald J Sokol · University Of Colorado Denver · U01 · FY2010 · DK
Soluble TNFa in the development of autonomic dysreflexia after spinal cord injury
$629,260Veronica Jean Tom · Drexel University · R01 · FY2018 · NS
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
$629,186Robert G Weiss · Johns Hopkins University · R01 · FY2015 · HL
ARIC Neurocognitive Study (ARIC-NCS)
$629,145David J Couper · Univ Of North Carolina Chapel Hill · U01 · FY2012 · HL
Asian American Community Cohort and Equity Study (ACCESS)
$629,098Carolyn Y Fang · Research Inst Of Fox Chase Can Ctr · UG3 · FY2024 · HL
Identifying Cardiotoxic Manifestations of Posttraumatic Psychopathology: A Population-based Longitudinal Investigation
$629,074Jennifer A Sumner · University Of California Los Angeles · R01 · FY2023 · HL
Intrinsic and synaptic determinants of SNc DA neuron activity and vulnerability
$629,050Dalton James Surmeier · Northwestern University At Chicago · P50 · FY2008 · NS
Passive heat therapy for lowering systolic blood pressure and improving vascular function in mid-life and older adults
$629,045Douglas R Seals · University Of Colorado · R01 · FY2023 · AG
Large Data Spatiotemporal Modeling of Optimal Combinations of Interventions to Reduce Opioid Harm in the United States
$629,040Magdalena Cerda · New York University School Of Medicine · R01 · FY2023 · DA
A double-blind randomized controlled trial to assess the efficacy and safety of a quadruple ultra-low dose treatment for hypertension (QUARTET USA)
$629,010Mark D Huffman · Washington University · R33 · FY2022 · HL
Racism, Coping and Ambulatory Blood Pressure
$628,938St. John'S University · R01 · FY2004 · HL
Decoding the Molecular and Cellular Mechanisms of Mutant KRAS-driven Brain Arteriovenous Malformations
$628,930Joshua D. Wythe · University Of Virginia · R01 · FY2024 · HL
Live cell and HCS assays to quantify production of cardiomyocytes from stem cells
$628,906Patrick M McDonough · Vala Sciences, Inc. · R42 · FY2008 · HL
Metabolic reprogramming of smooth muscle cells in pulmonary hypertension
$628,894Stephen M Black · Florida International University · R01 · FY2024 · HL
CARDIA-PLUS: A Life Course Investigation of Biopsychosocial Pathways to Bladder Health and Lower Urinary Tract Symptoms
$628,891Sonya S Brady · University Of Minnesota · R01 · FY2023 · DK
Intervention Targeting Medication Adherence and Methamphetamine Use for HIV + Men
$628,880Jeffrey T Parsons · Hunter College · R01 · FY2007 · DA
Essential Hypertension and Human Skin Blood Flow
$628,878Lacy M. Alexander · Pennsylvania State University, The · R01 · FY2015 · HL
Assessment of Retinal Capillary Density, Morphology and Function in Retinal Vascular Disease Using Novel OCT Angiography Based Metrics
$628,877Amir H Kashani · University Of Southern California · R01 · FY2019 · EY
Genetic and Environmental Risk Factors for PSP
$628,868Irene Litvan · University Of Louisville · R01 · FY2006 · AG
Epigenetic Regulation of Lysosomal Ceramide Signaling and Function in Arterial Myocytes: Role of Kmt6 Gene
$628,857Yang Zhang · University Of Houston · R01 · FY2021 · HL